MS-275, a Class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MS-275, a Class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 129, Issue 3, Pages 509-515
Publisher
Wiley
Online
2013-10-22
DOI
10.1111/jnc.12498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
- (2013) Benjamin E. L. Lauffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Mechanisms in Cerebral Ischemia
- (2013) Sophie Schweizer et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons
- (2013) C. Brochier et al. JOURNAL OF NEUROSCIENCE
- Disassociation of Histone Deacetylase-3 from Normal Huntingtin Underlies Mutant Huntingtin Neurotoxicity
- (2013) F. H. Bardai et al. JOURNAL OF NEUROSCIENCE
- Novel Protective Effects of Histone Deacetylase Inhibition on Stroke and White Matter Ischemic Injury
- (2013) Selva Baltan et al. Neurotherapeutics
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
- (2012) Angelina V. Vaseva et al. CELL
- Histone deacetylase inhibitors preserve function in aging axons
- (2012) Selva Baltan JOURNAL OF NEUROCHEMISTRY
- Epigenetic mechanisms in neurological disease
- (2012) Mira Jakovcevski et al. NATURE MEDICINE
- Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage
- (2011) Bing Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Transcription factor p53 influences microglial activation phenotype
- (2011) Suman Jayadev et al. GLIA
- Histone Deacetylase Inhibitors Preserve White Matter Structure and Function during Ischemia by Conserving ATP and Reducing Excitotoxicity
- (2011) S. Baltan et al. JOURNAL OF NEUROSCIENCE
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- Epigenetics: an Expanding New Piece of the Stroke Puzzle
- (2011) William J. Pearce Translational Stroke Research
- Expression of Histone Deacetylases in Cellular Compartments of the Mouse Brain and the Effects of Ischemia
- (2011) Selva Baltan et al. Translational Stroke Research
- Emerging Role of Epigenetics in Stroke
- (2010) Irfan A. Qureshi et al. ARCHIVES OF NEUROLOGY
- Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
- (2010) Ya-Li Yao et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies
- (2010) Claire L. Gibson et al. JOURNAL OF NEUROCHEMISTRY
- NRF2, cancer and calorie restriction
- (2010) A Martín-Montalvo et al. ONCOGENE
- Targeting the correct HDAC(s) to treat cognitive disorders
- (2010) André Fischer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia
- (2009) Tae Gen Son et al. JOURNAL OF NEUROCHEMISTRY
- Histone Deacetylase Inhibitors Prevent p53-Dependent and p53-Independent Bax-Mediated Neuronal Apoptosis through Two Distinct Mechanisms
- (2009) T. Uo et al. JOURNAL OF NEUROSCIENCE
- Focal Nature of Neurological Disorders Necessitates Isotype-Selective Histone Deacetylase (HDAC) Inhibitors
- (2009) Elizabeth A. Thomas MOLECULAR NEUROBIOLOGY
- HDAC2 negatively regulates memory formation and synaptic plasticity
- (2009) Ji-Song Guan et al. NATURE
- Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development
- (2009) R. L. Montgomery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Histone Deacetylases as a Multifaceted Approach to Treat the Diverse Outcomes of Stroke
- (2009) Brett Langley et al. STROKE
- Epigenetics: molecular mechanisms and implications for disease
- (2009) Adam E. Handel et al. TRENDS IN MOLECULAR MEDICINE
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- HDAC2: a critical factor in health and disease
- (2009) Oliver H. Krämer TRENDS IN PHARMACOLOGICAL SCIENCES
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Pulse Inhibition of Histone Deacetylases Induces Complete Resistance to Oxidative Death in Cortical Neurons without Toxicity and Reveals a Role for Cytoplasmic p21waf1/cip1 in Cell Cycle-Independent Neuroprotection
- (2008) B. Langley et al. JOURNAL OF NEUROSCIENCE
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
- (2008) Dohoon Kim et al. NEURON
- Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells
- (2007) Glen W. Humphrey et al. DIFFERENTIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now